Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Dermatomyositis × Sodium Chloride × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 32 Colorectal Neoplasms 12 Neoplasms 11 Pain, Postoperative 10 Lung Neoplasms 9 Brain Neoplasms 8 Stomach Neoplasms 7 Prostatic Neoplasms 7 Pancreatic Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Melanoma 6 Leukemia, Myeloid, Acute 5 Ovarian Neoplasms 4 Myoma 4 Lymphoma, Non-Hodgkin 4 Leiomyoma 4 Hemorrhage 4 Glioblastoma 4 Colonic Neoplasms 4 Agnosia 4 Skin Neoplasms 3 Recurrence 3 Rectal Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Neurotoxicity Syndromes 3 Neoplasm Metastasis 3 Nasopharyngeal Carcinoma 3 Myelodysplastic Syndromes 3 Multiple Endocrine Neoplasia Type 1 3 Meningioma 3

Interventions

cabozantinib 1 Specimen Handling 1 Sodium Chloride 1 Platinum Compounds 1 Nivolumab 1 Ipilimumab 1 Etanercept 1 CTLA-4 Antigen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00112385 2011-06-21

A Pilot Study of Etanercept in Dermatomyositis

Brigham and Women's Hospital

Phase 1 Completed

16 enrolled 42 charts

Dermatomyositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡